# Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer

> **NCT01916837** · — · COMPLETED · sponsor: **Jules Bordet Institute** · enrollment: 180 (actual)

## Conditions studied

- Invasive Breast Cancer

## Interventions

- **OTHER:** Sampling of tumor tissue
- **OTHER:** Sampling of tumor tissue after breast cancer surgery
- **PROCEDURE:** Sampling of tumor tissue after breast cancer surgery

## Key facts

- **NCT ID:** NCT01916837
- **Lead sponsor:** Jules Bordet Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2013-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01916837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01916837, "Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01916837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*